Phenyltriazolinones as potent factor Xa inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 4, 2010, Pages 1373-1377

  Quan, Mimi L ^a   Pinto, Donald J P ^a   Rossi, Karen A ^a   Sheriff, Steven ^a   Alexander, Richard S ^a   Amparo, Eugene ^a   Kish, Kevin ^a   Knabb, Robert M ^a   Luettgen, Joseph M ^a   Morin, Paul ^a   Smallwood, Angela ^a   Woerner, Francis J ^a   Wexler, Ruth R ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Coagulation; Factor Xa inhibitors

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; PHENYLTRIAZOLINONE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; LIPOPHILICITY; SUZUKI REACTION;

ANTICOAGULANTS; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; FACTOR XA; HUMANS; ISOXAZOLES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PYRAZOLES; PYRIDONES; SULFONES;

EID: 75449086587     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.01.011     Document Type: Article

References (31)

1. CDC/NCHS/AHA, 2003 data.
2. Hirsh J., O'Donell M., and Weitz J.I. Blood 105 (2005) 453
3. Golino P., Loffredo F., Riegler L., Renzullo E., and Cocchia R. Curr. Opin. Invest. Drugs 6 (2005) 298
4. Haas S. J. Thromb. Thrombolysis 25 (2008) 52
5. Eriksson B.I., Quinlan D.J., and Weitz J.I. Clin. Pharmacokinet. 48 (2009) 1
6. Hammwöhner M., and Goette A. J. Cardiovasc. Pharmacol. 52 (2008) 18
7. Spyropoulos A.C. Thromb. Res. 123 (2008) S29
8. Piccini J.P., Patel M.R., Mahaffey K.W., Fox K.A.A., and Califf R.M. Expert Opin. Investig. Drugs 17 (2008) 925
9. Drout L., and Bal dit Sollier C. Eur. J. Clin. Invest. 35 (2005) 21
10. Mann K.G., Butenas S., and Brummel K. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 17
11. Leadley Jr. R.J. Curr. Topics Med. Chem 1 (2001) 151
12. Hauptmann J., and Stürzebecher J. Thromb. Res. 93 (1999) 203
13. Turpie A.G.G. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1238
14. Harenberg J. Therapy 5 (2008) 177
15. Carreiro J., and Ansell J. Expert Opin. Investig. Drugs 17 (2008) 1973
16. Lassen M.R., Ageno W., Borris L.C., Lieberman J.R., Rosencher N., Bandel T.J., Misselwitz F., and Turpie A.G.G. N. Eng. J. Med. 358 (2008) 2776
17. Khoo C.W., Tay K.H., and Lip G.Y.H. Int. J. Clin. Pract. (2009) 1
18. Bounameaux H. Swiss Med. Wkly. 139 (2009) 60
19. Pinto D.J.P., Orwat M.J., Wang S., Fevig J.M., Quan M.L., Amparo E., Cacciola J., Rossi K.A., Alexander R.S., Smallwood A.M., Luettgen J.M., Liang L., Aungst B.J., Wright M.R., Knabb R.M., Wong P.C., Wexler R.R., and Lam P.Y.S. J. Med. Chem. 44 (2001) 566
20. Wong P.C., Quan M.L., Crain E.J., Watson C.A., Wexler R.R., and Knabb R.M. J. Pharmacol. Exp. Ther. 292 (2000) 351
21. Quan M.L., Lam P.Y.S., Han Q., Pinto D.J., He M., Li R., Ellis C.D., Clark C.G., Teleha C.A., Sun J.H., Alexander R.S., Bai S.A., Luettgen J.M., Knabb R.M., Wong P.C., and Wexler R.R. J. Med Chem. 48 (2005) 1729
22. Wong P.C., Crain E.J., Watson C.A., Wexler R.R., Lam P.Y.S., Quan M.L., and Knabb R.M. J. Thromb. Thrombolysis (2007) 43
23. Pinto D.J.P., Orwat M.J., Koch S., Rossi K.A., Alexander R.S., Smallwood A., Wong P.C., Rendina A.R., Luettgen J.M., Knabb R.M., He K., Xin B., Wexler R.R., and Lam P.Y.S. J. Med. Chem. 50 (2007) 5339
24. He K., He B., Grace J.E., Zhang D., Pinto D.J., Luettgen J.M., Knabb R.M., Lam P.S.Y., Wexler R.R., Humphreys W., Shyu W., and Grossman S.J. Blood 108 (2006) 273
25. Lassen M.R., Davidson B.L., Gallus A., Pineo G., Ansell J., and Deitchman D. Blood 102 (2003) 15a Abstract 41
26. Lassen M.R., Davidson B.L., Gallus A., Pineo G., Ansell J., and Deitchman D. J. Thromb. Haemost. 5 (2007) 2368
27. Pinto D.J.P., Orwat M.J., Quan M.L., Han Q., Galemmo Jr. R.A., Amparo E., Wells B., Ellis C., He M.Y., Alexander R.S., Rossi K.A., Smallwood A., Wong P.C., Luettgen J.M., Rendina A.R., Knabb R.M., Mersinger L., Kettner C., Bai S., He K., Wexler R.R., and Lam P.Y.S. Bioorg. Med. Chem. Lett. 16 (2006) 4141
28. Pinto D.J.P., Galemmo Jr. R.A., Quan M.L., Orwat M.J., Clark C., Li R., Wells B., Woerner F., Alexander R.S., Rossi K.A., Samllwood A., Wong P.C., Luettgen J.M., Rendina A.R., Knabb R.M., He K., Wexler R.R., and Lam P.Y.S. Bioorg. Med. Chem. Lett. 16 (2006) 5584
29. PT values were measured according to Refs. 6b,7a.
30. The X-ray structures of 4b, 5a, and 5d-f in fXa were obtained using conditions similar to those described in Ref. 8a. The coordinates for these enzyme inhibitor structures have been deposited with the Protein Data Bank with the accession codes of 4b (3KQB), 5a (3KQC), 5d (3FFG), 5e (3KQD), and 5f (3KQE).
31. Delano, W. L. The PyMol Molecular Graphics System (2002). Delano Scientific, San Carlos, CA, US. http://www.pymol.org.